Metered Dose Inhaler Propellant Transition: US FDA Eager To Avoid Replay Of CFC-To-HFA ‘Complexity’

 
• By Michael McCaughan
  
The FDA wants the transition to "low global warming potential" metered dose inhaler propellants to have a minimal impact on patients. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Pathways & Standards